Safety and tolerability of atopaxar in the treatment of patients with acute coronary syndromes: the lessons from antagonizing the cellular effects of Thrombin–Acute Coronary Syndromes Trial.

Source:http://linkedlifedata.com/resource/pubmed/id/21502577

Circulation 2011 May 3 123 17 1843-53

Download in:

View as

General Info

PMID
21502577